Switching from rituximab to eculizumab in patients with AQP4+NMOSD in the United States: Impact on hospitalisations and comorbidities

被引：0
|
作者：
Lee, Justin [1 ]
Kielhorn, Adrian [1 ]
Fam, Sami [1 ]
Riser, Emily [2 ]
Flanagan, Eoin [3 ]
机构：
[1] Alexion, AstraZeneca Rare Dis, Boston, MA USA
[2] Alabama Neurol Associates, Birmingham, AL USA
[3] Mayo Clin, Dept Neurol, Rochester, MN USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P358/1445
引用
收藏
页码：391 / 392
页数：2
相关论文
共 50 条
  • [31] Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States
    Tan, Xi
    Yang, Lingfeng
    Khunti, Kamlesh
    Zhang, Ruya
    Zhang, Ye
    Rajpathak, Swapnil
    Yu, Miao
    DIABETES OBESITY & METABOLISM, 2021, 23 (10): : 2251 - 2260
  • [32] Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database
    Steven R. Feldman
    Haijun Tian
    Isabelle Gilloteau
    Patrick Mollon
    Meng Shu
    BMC Health Services Research, 17
  • [33] What percentage of aqp4-ab-negative nmosd patients are mog-ab positive? A study from the argentinean multiple sclerosis registry (RELEVAREM)
    Carnero Contentti, E.
    Lopez, P.
    Pettinicchi, J.
    Pappolla, A.
    Miguez, J.
    Patrucco, L.
    Cristiano, E.
    Vrech, C.
    Tkachuk, V.
    Liwacki, S.
    Correale, J.
    Marrodan, M.
    Gaitan, M.
    Fiol, M.
    Negrotto, L.
    Ysrraelit, M.
    Burgos, M.
    Leguizamon, F.
    Tavolini, D.
    Deri, N.
    Balbuena, M. E.
    Mainella, C.
    Luetic, G.
    Blaya, P.
    Hryb, J.
    Menichini, M.
    Alves Pinheiro, A.
    Nofal, P.
    Zanga, G.
    Barboza, A.
    Martos, I.
    Lazaro, L.
    Silva, E.
    Bestoso, S.
    Fracaro, M. E.
    Carra, A.
    Garcea, O.
    Fernandez Liguori, N.
    Alonso Serena, M.
    Caride, A.
    Rojas, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 482 - 482
  • [34] What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)
    Carnero Contentti, Edgar
    Lopez, Pablo A.
    Pablo Pettinicchi, Juan
    Pappolla, Agustin
    Miguez, Jimena
    Patrucco, Liliana
    Cristiano, Edgardo
    Vrech, Carlos
    Tkachuk, Veronica
    Liwacki, Susana
    Correale, Jorge
    Marrodan, Mariano
    Gaitan, Maria, I
    Fiol, Marcela
    Negrotto, Laura
    Ysrraelit, Maria C.
    Burgos, Marcos
    Leguizamon, Felisa
    Tavolini, Dario
    Deri, Norma
    Balbuena, Maria E.
    Mainella, Carolina
    Luetic, Geraldine
    Blaya, Patricio
    Hryb, Javier
    Menichini, Maria L.
    Alvez Pinheiro, Amelia
    Nofal, Pedro
    Zanga, Gisela
    Barboza, Andres
    Martos, Ivan
    Lazaro, Luciana
    Alonso, Ricardo
    Silva, Emanuel
    Bestoso, Santiago
    Fracaro, Maria E.
    Carra, Adriana
    Garcea, Orlando
    Fernandez Liguori, Nora
    Alonso Serena, Marina
    Caride, Alejandro
    Rojas, Juan, I
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [35] Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients
    Carnero Contentti, Edgar
    Marques, Vanessa Daccach
    de Castillo, Ibis Soto
    Tkachuk, Veronica
    Barreira, Amilton Antunes
    Caride, Alejandro
    Castillo, Maria C.
    Cristiano, Edgardo
    Cruz, Camila de Aquino
    Diegues Serva, Gabriel Braga
    dos Santos, Antonio Carlos
    Labarca, Rossanny
    Moreira, Carolina Lavigne
    Lopez, Pablo A.
    Miguez, Jimena
    Molina, Omaira
    Pablo Pettinicchi, Juan
    Ignacio Rojas, Juan
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (08) : 945 - 954
  • [36] COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME
    Levy, A.
    Chen, P. G. F.
    Tomazos, I
    VALUE IN HEALTH, 2019, 22 : S841 - S841
  • [37] Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States
    Chau, Jason
    Delate, Thomas
    Ota, Taylor
    Bhardwaja, Bharati
    ACR OPEN RHEUMATOLOGY, 2019, 1 (01) : 52 - 57
  • [38] Trends in infective endocarditis hospitalisations at United States children's hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines
    Bates, Katherine E.
    Hall, Matthew
    Shah, Samir S.
    Hill, Kevin D.
    Pasquali, Sara K.
    CARDIOLOGY IN THE YOUNG, 2017, 27 (04) : 686 - 690
  • [39] The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States
    Bin Ng, Daniel
    Espinosa, Robert
    Johnson, Scott J.
    Walker, David
    Gooch, Katherine
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1272 - 1280
  • [40] Impact of Atrial Fibrillation in Aortic Stenosis Patients: Insights From the United States Readmissions Database
    Shekhar, Shashank
    Saad, Anas M.
    Isogai, Toshiaki
    Gad, Mohamed M.
    Ahuja, Keerat
    Kaur, Manpreet
    Verma, Beni R.
    Vaidya, Prashansha
    Abdelfattah, Omar M.
    Kassis, Nicholas
    Reed, Grant W.
    Puri, Rishi
    Krishnaswamy, Amar
    Kapadia, Samir R.
    CIRCULATION, 2020, 142
12345